The drug, CUTX-101, is intended for the treatment of Menkes disease, a rare X-linked recessive genetic disorder affecting male children
Source :- Companies Read More
Zydus Life’s US arm gets FDA nod for Menkes disease drug resubmission
- No Comments
- 6 Min Read
Share it :
